Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sanguine Media Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 531898

₹0.19

₹0.00 (0.00%)

As on 06-Jan-2020IST

Market cap

info icon

₹2 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -85.57 -- --
EBIT -128.57 44.83 61.41 9.98 5.77
Net Profit 114.29 -50.00 97.39 -112.44 14.11
EPS 116.67 -50.00 97.74 -111.81 14.85
Book Value -- -- -0.13 -0.61 -0.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -209.58-209.58-507.14---209.58
Net Margin info -2,130.70-2,130.70-4.94---2,130.70
Return on equity info -0.61-0.680.00-0.13-3.32
Return on Capital info -1.10-0.95---0.13-3.16
Return on Assets info -0.57-0.590.00-0.12-2.92
Debt to Equity (x) info ----0.000.010.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
-0.13
-3.16
-0.01
-0.01
Peer Median
--
23.63
29.42
12.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

0.00

Lower than Peers by 9.86

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
0.00
-0.13
-3.32
1.61
-0.01
Peer Median
9.86
21.21
21.33
9.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.00

Lower than Peers by 7.47

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
0.00
-0.12
-2.92
1.32
0.00
Peer Median
7.47
12.84
11.88
8.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-507.14

Lower than Peers by 516.27

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
-507.14
--
-209.58
--
--
Peer Median
9.12
11.31
--
19.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-4.94

Lower than Peers by 16.23

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
-4.94
-130.45
-2,130.70
1,513.88
-15.85
Peer Median
11.29
15.45
15.30
19.82
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
-4,317.47
--
--
Peer Median
--
--
--
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-85.57

Lower than Peers by 87.41

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
-85.57
-100.00
--
--
--
Peer Median
1.84
47.97
--
-0.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

61.41

Higher than Peers by 50.99

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
61.41
-41.79
-32.12
-203.22
97.48
Peer Median
10.43
31.56
--
-12.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

97.39

Higher than Peers by 90.77

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
97.39
96.10
-304.32
--
99.65
Peer Median
6.62
43.57
--
5.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

97.74

Higher than Peers by 96.44

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
97.74
96.11
-304.38
--
99.64
Peer Median
1.30
-23.32
--
-1.24
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
-0.13
-3.27
1.62
-0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
0.01
0.01
0.09
0.09
Peer Median
--
0.05
0.05
0.07
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
0.01
0.01
0.09
0.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

34.40

Higher than Peers by 31.13

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
34.40
34.46
5.94
3.38
2.53
Peer Median
3.27
3.30
2.74
4.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

27.19

Higher than Peers by 23.93

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
27.19
27.23
4.87
2.61
1.96
Peer Median
3.26
18.81
--
5.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
22.38
127.53
77.84
299.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

1,09,314.29

Higher than Peers by 1,09,290.98

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
1,09,314.29
--
16,109.79
--
--
Peer Median
23.30
39.40
--
29.18
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.00

Lower than Peers by 0.66

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
0.00
--
0.00
--
--
Peer Median
0.66
1.13
--
0.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
7.29
31.15
25.58
34.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.02

Lower than Peers by 0.63

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
0.02
--
--
--
--
Peer Median
0.65
4.23
4.69
2.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
--
--
--
--
--
Peer Median
0.48
--
0.39
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-216.96

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
-216.96
-721.56
-1,134.86
-6,936.03
--
Peer Median
--
30.85
23.59
32.66
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

2

Lower than Peers by 781

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sanguine Media
2
--
--
--
--
Peer Median
783
761
1,254
688
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...